Meiser BM and Reichart B |
New trends in clinical immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527954
|
Nakajima K et al. |
Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679821
|
Ohtsuka S et al. |
Hamster-to-rat xenotransplantation of whole pancreas by FK 506 combined with splenectomy. |
1994 |
Transplant. Proc. |
pmid:7513473
|
Risaliti A et al. |
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750569
|
Tanabe K et al. |
Prospective analysis and successful treatment of thrombotic microangiopathy in renal allografts under tacrolimus immunosuppression. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750571
|
Goto T et al. |
FK 506: historical perspectives. |
1991 |
Transplant. Proc. |
pmid:1721254
|
Ochiai T et al. |
Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantation. |
1991 |
Transplant. Proc. |
pmid:1721255
|
Ciancio G et al. |
Current advantage of FK 506 in cadaveric kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623207
|
Vanrenterghem Y et al. |
Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636523
|
Tanabe K et al. |
Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119897
|
Claesson K et al. |
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients. |
1998 |
Transplant. Proc. |
pmid:9636524
|
Lye WC |
Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience. |
2000 |
Transplant. Proc. |
pmid:11119898
|
Bruce DS et al. |
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9532150
|
Peddi VR et al. |
Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9532151
|
Ben-Ari Z et al. |
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12644067
|
Gutiérrez Sánchez MJ et al. |
Optimization of immunosuppression by switching from azathioprine to enteric-coated mycophenolate sodium in stable kidney transplant patients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715907
|
Staschak S et al. |
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. |
1990 |
Transplant. Proc. |
pmid:1689896
|
Lladó L et al. |
Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:11959210
|
Aptaramanov B et al. |
A comparison of mycophenolate mofetil with mycophenolate sodium in renal transplant recipients on tacrolimus-based treatment. |
2011 |
Transplant. Proc. |
pmid:21486609
|
Ma A et al. |
Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808578
|
Osako M et al. |
Alloimmune response may be involved in neointimal hyperplasia in cryopreserved aortic allografts. |
2001 |
Transplant. Proc. |
pmid:11406250
|
Mañez R et al. |
Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7680170
|
Müller MK et al. |
Inhibition of insulin release by FK 506 and its prevention by rioprostil, a stable prostaglandin E1 analogue. |
1991 |
Transplant. Proc. |
pmid:1721286
|
Ketel BL et al. |
Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation. |
1996 |
Transplant. Proc. |
pmid:8623453
|
Mueller AR et al. |
Does initial graft function influence the outcome after liver transplantation? |
1998 |
Transplant. Proc. |
pmid:9636594
|
Oishi M et al. |
A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120143
|
Soriano S et al. |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576045
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
Takeuchi H et al. |
Lymphocyte sensitivity to cyclosporine and tacrolimus in chronic renal failure patients and clinical significance in renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9474950
|
DÃaz-Molina B et al. |
Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation. |
2012 |
Transplant. Proc. |
pmid:23146479
|
Liu M et al. |
C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. |
2004 |
Transplant. Proc. |
pmid:15518760
|
Deardon DJ et al. |
Small bowel tonometry: a possible technique for detecting early small bowel allograft dysfunction. |
1993 |
Transplant. Proc. |
pmid:7505502
|
Hayashi S et al. |
Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation. |
1994 |
Transplant. Proc. |
pmid:7518126
|
Ohtsuka S et al. |
Mechanism of antibody production in guinea pig to rat discordant xenotransplant: establishment of a simple model by intravenous injection of discordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518130
|
Marente VC et al. |
Modigraf administration through jejunostomy in liver transplant recipient: case report. |
2013 |
Transplant. Proc. |
pmid:24314992
|
Woodle ES et al. |
FK 506 rescue therapy: early conversion improves efficacy. |
1993 |
Transplant. Proc. |
pmid:7682359
|
Loss M et al. |
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients. |
1995 |
Transplant. Proc. |
pmid:7533365
|
Yagihashi A et al. |
The effect of FK 506 on peripheral blood T-lymphocyte subsets in orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721318
|
Ziolkowski J et al. |
Effect of immunosuppressive regimen on acute rejection and liver graft function. |
2003 |
Transplant. Proc. |
pmid:14529915
|
Kato T et al. |
FK506 may suppress liver injury during the early period following living-related liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12591316
|
Bahra M et al. |
Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. |
2005 |
Transplant. Proc. |
pmid:15919436
|
Maes BD and Vanrenterghem YF |
Cyclosporine: advantages versus disadvantages vis-Ã -vis tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15041305
|
Ã…berg F et al. |
Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. |
2015 |
Transplant. Proc. |
pmid:26680092
|
Malireddy SR et al. |
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. |
2008 |
Transplant. Proc. |
pmid:18589198
|
Braun F et al. |
Therapeutic drug monitoring of tacrolimus early after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176473
|
Tashiro H et al. |
Monitoring for engraftment of rat orthotopic liver transplantation by semiquantitative PCR. |
1995 |
Transplant. Proc. |
pmid:7533421
|
Schorlemmer HU et al. |
Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9865312
|
Felser I et al. |
Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721350
|
Chiereghin A et al. |
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172283
|
Dierickx D et al. |
Thrombotic microangiopathy following intestinal transplantation: a single center experience. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172285
|
Nanni G et al. |
Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression. |
2002 |
Transplant. Proc. |
pmid:12270323
|
Pape L et al. |
Long-term stable glomerular filtration rate achieved with tacrolimus in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12270367
|
Prasad GV et al. |
Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. |
2005 |
Transplant. Proc. |
pmid:15919496
|
Walgenbach KJ et al. |
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. |
1996 |
Transplant. Proc. |
pmid:8907896
|
Miyagi M et al. |
Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression. |
2002 |
Transplant. Proc. |
pmid:12176497
|
Nüssler NC et al. |
CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection. |
1996 |
Transplant. Proc. |
pmid:8907898
|
van Hooff JP et al. |
Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results. |
2002 |
Transplant. Proc. |
pmid:12176498
|
Malaise J et al. |
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182827
|
Zmonarski SC et al. |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. |
2016 |
Transplant. Proc. |
pmid:27496439
|
Oishi M et al. |
Successful swine small bowel transplantation using FK506: effect on endotoxin translocation. |
1994 |
Transplant. Proc. |
pmid:7520629
|
Moutabarrik A et al. |
FK 506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro. |
1991 |
Transplant. Proc. |
pmid:1721382
|
Takeda M et al. |
Immunologic factors contributing to acute rejection in lungs xenotransplanted between primates. |
1998 |
Transplant. Proc. |
pmid:9838670
|
Murase N et al. |
Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083238
|
Endoh M et al. |
Nonmuscle myosin heavy chain and metalloproteinase-2 expression in concordant pulmonary xenografts. |
2000 |
Transplant. Proc. |
pmid:10936397
|
Gassel HJ et al. |
Selective immunosuppression induces tolerance after liver transplantation: an immunohistochemical and cytofluorographic analysis of the graft and recipient immune system. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123253
|
Kliem V et al. |
FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. |
1996 |
Transplant. Proc. |
pmid:8962227
|
Citterio F et al. |
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176545
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Chang HR et al. |
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients. |
2007 |
Transplant. Proc. |
pmid:17580178
|
Jiang H et al. |
IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266931
|
Orsenigo R et al. |
FK506 and SMS 201-995: effect on heterotopic heart transplantation in rats. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266956
|
Ohtsuka S et al. |
The effect of short-term FK 506 therapy on pancreas transplantation in rats. |
1991 |
Transplant. Proc. |
pmid:1721413
|
Tanabe K et al. |
Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658670
|
Nakao A et al. |
Cytokine mRNA expression on rat small bowel allograft treated with tacrolimus and simultaneous bone marrow transplantation via the portal vein. |
2000 |
Transplant. Proc. |
pmid:10995965
|
Yamashita T et al. |
Prolongation of pancreaticoduodenal allograft survival in rats by treatment with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721414
|
Sugito K et al. |
A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658683
|
Soltero L et al. |
Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects. |
2003 |
Transplant. Proc. |
pmid:12826147
|
Langer RM et al. |
De novo tumors after kidney transplantation: the Budapest experience. |
2003 |
Transplant. Proc. |
pmid:12826170
|
Glanemann M et al. |
Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A. |
2000 |
Transplant. Proc. |
pmid:10812095
|
McMaster P et al. |
Liver transplantation: changing goals in immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9723295
|
Fábrega E et al. |
Effect of immunosuppressant blood levels on serum concentration of interleukin-17 and -23 in stable liver transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19376417
|
Tahir W et al. |
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. |
|
Transplant. Proc. |
pmid:25645795
|
Burke GW et al. |
Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen. |
2002 |
Transplant. Proc. |
pmid:12176628
|
Kovarik JM et al. |
Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus. |
2006 |
Transplant. Proc. |
pmid:17175302
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Mühlbacher F |
Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267317
|
Duzova A et al. |
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. |
2003 |
Transplant. Proc. |
pmid:14697926
|
Lin CY et al. |
Effects of FK 506 on the biochemical markers in canine lung allograft rejection. |
1991 |
Transplant. Proc. |
pmid:1721445
|
Morales E et al. |
Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection. |
1999 |
Transplant. Proc. |
pmid:10500562
|
Jost U et al. |
FK 506 treatment of intractable rejection after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689276
|
Nardo B et al. |
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. |
2000 |
Transplant. Proc. |
pmid:11134771
|
Miyata Y et al. |
Development of xenogeneic microchimerism correlated with graft outcome in hamster-to-rat heart xenotransplantation. |
1998 |
Transplant. Proc. |
pmid:9723548
|
Chamienia A et al. |
Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. |
2014 |
Transplant. Proc. |
pmid:25380901
|
Kocak H et al. |
Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose. |
2005 |
Transplant. Proc. |
pmid:16213288
|
Abou-Jaoude MM et al. |
Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients. |
2005 |
Transplant. Proc. |
pmid:16213293
|
Abe T et al. |
Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. |
2014 |
Transplant. Proc. |
pmid:24767367
|
Reimer J et al. |
Quality of life after kidney transplantation--the impact of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267573
|
McLaughlin GE et al. |
Effect of aminophylline on urine flow in children with tacrolimus-induced renal insufficiency. |
2000 |
Transplant. Proc. |
pmid:10856596
|
Fritsche L et al. |
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. |
1998 |
Transplant. Proc. |
pmid:9636481
|
Bresci S et al. |
Case report: cystic fibrosis, lung transplantation, and the novel H1N1 flu. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692461
|